Outcomes of hospitalisation and the 30-day prognosis
| Variable | Dapagliflozin group (n=50) | Control group (n=52) | P value |
| Intrahospital mortality, n (%) | 4 (8) | 4 (7.7) | 0.95 |
| Length of hospitalisation, days | 6 (5; 7) | 5.5 (4; 7) | 0.12 |
| 1-month mortality, n (%) | 9 (19) | 12 (25) | 0.55 |
| 1-month rehospitalisation, n (%) | 14 (29) | 17 (35) | 0.51 |
| Increasing the dose of loop, n (%), | 7 (14) | 16 (30) | 0.048 |
| Adding another class of diuretic drugs, n (%) | 5 (10) | 8 (15) | 0.66 |
| Mean doses of loop diuretics during hospitalisation (in furosemide equivalents), mg | 78.46±38.95 | 102.82±31.26 | 0.001 |
| Deterioration of renal function, n (%) | 17 (34.4) | 8 (15.2) | 0.07 |
| Weight loss during hospitalisation function, g | 4100 (2950; 5750) | 3000 (1380; 4650) | 0.02 |
Values are mean±SD or n (%).